Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19436468
Conclusion of this study
A subgroup of children with ADHD who used n-3 PUFA supplements achieved and maintained symptom control. The data of the present study also supported n-3 PUFA safety and tolerability, but limited changes were noted in the FA profile in French Canadians with ADHD.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study